| Tag | Content |
|---|
EnhancerAtlas ID | HS093-28343 |
Organism | Homo sapiens |
Tissue/cell | HL-60 |
Coordinate | chr7:50477090-50478590 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| NKX2-3 | MA0672.1 | chr7:50477240-50477250 | TTCAAGTGGT | - | 6.02 | | Pou2f3 | MA0627.1 | chr7:50477725-50477741 | GGGAATTTGCATAATA | - | 6.2 | | SP8 | MA0747.1 | chr7:50477587-50477599 | CCCACGCCCCCT | + | 6.04 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_09412 | chr7:50468289-50485837 | CD14 | | SE_10357 | chr7:50471995-50482114 | CD19_Primary | | SE_10918 | chr7:50410368-50486056 | CD20 | | SE_61918 | chr7:50458805-50486267 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 4 | Chromosome | Start | End |
| chr7 | 50477149 | 50477200 | | chr7 | 50477166 | 50477259 | | chr7 | 50477382 | 50477512 | | chr7 | 50477586 | 50478539 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH07I050409 | chr7 | 50476766 | 50479811 |
|
Enhancer Sequence | GATAGGAAAA CTCATTGGGG ACAGCATCTC AGAATTGTTT TTTTAATTCA AAAGAAGAGG 60
CCCACAAATA GGTTCAACAA AGCCAATGCA ATAAGGAAGG GGGCAGAGAT GAGACCACTG 120
AGTCAAGTGT TTAGGATGCT GGCAATGACC TTCAAGTGGT GGGTGACAGT GGACTGCAAG 180
GGTGGGCAGA GATGGGCTCT GGAGAGCAGC CGGCAAAGAA GACAGGACCC TGCAATGCAG 240
CCCAGGCCTC ATGGAGGCCG ATGCTTTGGA AAGGCCAAGT TCTTGGCTGC ACTTTTCTAA 300
GGAGAAAGGT AAGAGCCTCA TGGGGATACT CCCTTGCTTT TTCTGCTTTT TGACATGGCC 360
AAGACAGGAA CAAGGCAGAC ATCCCTAGAA CTCTGTCTCC TGTCCACGTC TGGGATCTGG 420
GCTTCTCAAG GCAGGCTGCA TCACCTTCCA GCTCCAGGAG TGGCCCTGCA GGTCCTGGAG 480
CAACAGCCTG GCCCCTGCCC ACGCCCCCTC CTCCCTGGCC GCAGGCCCTG GGCCTGGGCT 540
GAGCAGATGG GCCCTGGCAA CTCGGTGAAT CGGAACTATG GGAAGCAGAT GCACCCGCCA 600
TGGGTCCCCG GGCACAACTG GAACCTGCTG GGGGAGGGAA TTTGCATAAT AAGGATAATT 660
TGGTACCAAA ACTGTCCCCT GAAGTGAACT GCATGGATCT CGATACAGTT AACAAATTTC 720
ACTTCTTCTT TCCCATGTTT TGTCAAACCA ACTAGTTGTG ACGTTGAGTG TGTGAATTGT 780
CCCAATGTTT CTGTTTCTCT GCCCATGAGT CAGCCCTGGC TTCTCTCTCT GCTTTGCTAC 840
CCCCCTGGGC CTGAGGAGGT ACCATGCACA TGCATATGGG CCTCTCCTGA ACAAGGCCAC 900
CCTAAGACCT CTCTCTGTGG TTGCGACCAC ATGTGATCCC AGGTTCCCAG AAGGCCTCAG 960
TGGCTGCGGC CTCCTCTCCG CCACCGTCTC ACGGTGCTGT TCCTCCCCAG GCACCTGCGC 1020
GAGCTTCCTC ATTGTCATTC TCCCTCCAGC TTCCTGTGGG TAGAGGGTGG GCTGGGCCCC 1080
ACAGTAAGGA GGGTGTGCAG TTTCAGGGTC CCTCAATTTG ATTCCCCTTT CAGGGACCTC 1140
CTCCCTCTGG GCACTGCCCT GATCCCCACC CTCAGTGGGC ACTGCCCCTT GCAAAATCCT 1200
CTGTAAATCC CCTCTGCCCA CACCCACTTC CCACCTCTGT GAGCACCACG ATTCCTTTTT 1260
TAAGTTGGTC TCTCATACCA CCCCATGGGA GAATGGTTGT GTGTTTTCGT GCACTGATGG 1320
GAAATTAAAG CTGACAAGCA TGGAGGCAGG GACCCCAAGA GCTGAGGGAA GCTGGTCAGC 1380
TGGTCTCCCA GGTCAGATCT CATCTTCAGG AAGGCATCCA TCCTCAGTGA GATGTGACCC 1440
CAGATGATCC CCCAGCCTCC TCCCAACCTC CAAATCACAC CCGATTCCCA GGTTTCCTCG 1500
|
